Reaction
Bone Marrow Oedema reporting signals
As of the last recalculation, Bone Marrow Oedema appears in 1,024 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is IMATINIB (PRR 27.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Imatinib | 23 | 27.1 | 27.1 |
| Sulfasalazine | 70 | 19.4 | 19.5 |
| Diclofenac Potassium, Film Coated | 7 | 17.0 | 17.0 |
| Diclofenac Potassium Tablets | 7 | 17.0 | 17.0 |
| Imatinib Mesylate | 21 | 15.6 | 15.6 |
| Basiliximab | 8 | 13.9 | 13.9 |
| Diclofenac Potassium | 7 | 13.3 | 13.3 |
| Misoprostol | 6 | 12.6 | 12.6 |
| Bosutinib | 5 | 11.4 | 11.4 |
| Mirabegron | 21 | 11.2 | 11.2 |
| Sitagliptin And Metformin Hydrochloride | 11 | 10.5 | 10.5 |
| Dasatinib | 16 | 8.9 | 8.9 |
| Polatuzumab Vedotin | 3 | 6.3 | 6.3 |
| Isotretinoin | 13 | 5.4 | 5.4 |
| Emicizumab | 3 | 4.9 | 4.9 |
| Romosozumab-Aqqg | 3 | 4.5 | 4.5 |